UshTher objective of developing a clinical trial to test both the safety and efficacy of subretinal administrations of dual AAV8 vectors in the retina of USHIB patients will be achieved through a unique, very competitive consortium which brings together academic and industrial Partners with internationally-recognized expertise in gene therapy and ophthalmology.

UShTher partners at a glance